Expand MLYS Menu
MLYS MENU

MLYS Latest Press Releases

-- May 27, 2026 --

Mineralys Therapeutics to Participate in the Jefferies Global Healthcare Conference Globe Newswire 8:00 AM

-- May 18, 2026 --

Mineralys Therapeutics Announces Presentation of New Data from the Phase 3 Launch-HTN Trial of Lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protection (ESH 2026) Globe Newswire 4:05 PM

-- May 6, 2026 --

Mineralys Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 4:05 PM

-- May 5, 2026 --

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 5:34 PM
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference Globe Newswire 8:00 AM

-- April 29, 2026 --

Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026 Globe Newswire 4:05 PM

-- March 24, 2026 --

Mineralys Therapeutics Appoints Jeffrey A. Munsie as Chief Legal Officer Globe Newswire 8:00 AM

-- March 16, 2026 --

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- March 12, 2026 --

Mineralys Therapeutics Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update Globe Newswire 4:05 PM

-- March 9, 2026 --

Mineralys Therapeutics Announces FDA Acceptance of NDA for Lorundrostat for Treatment of Adults with Hypertension and Topline Explore-OSA Trial Results Globe Newswire 4:30 PM
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on Thursday, March 12, 2026 Globe Newswire 8:00 AM

-- March 3, 2026 --

Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight PRNewswire 5:31 PM

-- February 26, 2026 --

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- February 11, 2026 --

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:00 PM

-- January 6, 2026 --

Mineralys Therapeutics Provides Corporate Update and Announces Participation in Upcoming LifeSci Partners Corporate Access Event in January 2026 Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes